Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

Ítems similars

• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
  per: Friedman, E, et al.
  Publicat: (1998)
• Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
  per: Simchoni, Sharon, et al.
  Publicat: (2006)
• Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
  per: Kauff, N, et al.
  Publicat: (2002)
• Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and Non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976-1999
  per: Chodick, Gabriel, et al.
  Publicat: (2007)
• A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
  per: Levy-Lahad, E., et al.
  Publicat: (2001)